Results 41 to 50 of about 1,696,934 (300)

Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation. [PDF]

open access: yes, 2013
Dengue is a rapidly growing public health threat with approximately 2.5 billion people estimated to be at risk. Several vaccine candidates are at various stages of pre-clinical and clinical development.
Live Dengue Vaccines Technical Consultation Reporting Group   +8 more
core   +1 more source

EVALUATION OF SOME VACCINATION PROGRAMS AGAINST NEWCASTLE DISEASE VIRUS IN EXPERIMENTALLY CHALLENGED BROILER CHICKENS [PDF]

open access: yesAssiut Veterinary Medical Journal
The objective of the current study was to evaluate the efficiency of different vaccination programs in protecting experimentally challenged broiler chickens against the VV Strain of Newcastle disease virus.
HAITHAM IBRAHIM   +3 more
doaj   +1 more source

Live Attenuated Varicella Vaccine

open access: yesThe Journal of Pediatrics, 1984
Live attenuated varicella vaccine will in all probability soon be licensed in the United States for immunization of healthy children and adults and certain immunocompromised children. This vaccine can be expected to protect susceptibles from varicella (or to modify it) in those subsequently exposed to the wild virus.
openaire   +6 more sources

2399

open access: yesJournal of Clinical and Translational Science, 2017
OBJECTIVES/SPECIFIC AIMS: Determine whether children with solid tumors maintain intact protective immunity to live vaccines during cancer therapy and after completing cancer therapy (postTx). METHODS/STUDY POPULATION: We will perform a prospective cohort
Franchesca Garcia Robles   +2 more
doaj   +1 more source

Bovine Anaplasmosis: Will there ever be an almighty effective vaccine?

open access: yesFrontiers in Veterinary Science, 2022
Bovine anaplasmosis is a tick-borne bacterial disease with a worldwide distribution and the cause of severe economic losses in the livestock industry in many countries, including México.
Elizabeth Salinas-Estrella   +4 more
doaj   +1 more source

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

A stable live bacterial vaccine [PDF]

open access: yesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
Formulating vaccines into a dry form enhances its thermal stability. This is critical to prevent administering damaged and ineffective vaccines, and to reduce its final cost. A number of vaccines in the market as well as those being evaluated in the clinical setting are in a dry solid state; yet none of these vaccines have achieved long-term stability ...
Nitesh K. Kunda   +4 more
openaire   +2 more sources

Live Viral Vaccine Neurovirulence Screening: Current and Future Models

open access: yesVaccines, 2021
Live viral vaccines are one of the most successful methods for controlling viral infections but require strong evidence to indicate that they are properly attenuated.
Corey May Fulton, Wendy J. Bailey
doaj   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

Home - About - Disclaimer - Privacy